Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.

Morton LM, Purdue MP, Zheng T, Wang SS, Armstrong B, Zhang Y, Menashe I, Chatterjee N, Davis S, Lan Q, Vajdic CM, Severson RK, Holford TR, Kricker A, Cerhan JR, Leaderer B, Grulich A, Yeager M, Cozen W, Hoar Zahm S, Chanock SJ, Rothman N, Hartge P.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1259-70. doi: 10.1158/1055-9965.EPI-08-1037. Epub 2009 Mar 31.

2.

Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.

Kelly JL, Novak AJ, Fredericksen ZS, Liebow M, Ansell SM, Dogan A, Wang AH, Witzig TE, Call TG, Kay NE, Habermann TM, Slager SL, Cerhan JR.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2847-58. doi: 10.1158/1055-9965.EPI-10-0581. Epub 2010 Sep 20.

3.

Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.

Hu W, Bassig BA, Xu J, Zheng T, Zhang Y, Berndt SI, Holford TR, Hosgood HD 3rd, Leaderer B, Yeager M, Menashe I, Boyle P, Zou K, Zhu Y, Chanock S, Lan Q, Rothman N.

Environ Mol Mutagen. 2013 Jan;54(1):72-7. doi: 10.1002/em.21739. Epub 2012 Oct 11.

PMID:
23055202
4.

Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.

Guo H, Bassig BA, Lan Q, Zhu Y, Zhang Y, Holford TR, Leaderer B, Boyle P, Qin Q, Zhu C, Li N, Rothman N, Zheng T.

Cancer Causes Control. 2014 Oct;25(10):1261-70. doi: 10.1007/s10552-014-0423-1. Epub 2014 Sep 2.

5.

Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.

Wang SS, Purdue MP, Cerhan JR, Zheng T, Menashe I, Armstrong BK, Lan Q, Hartge P, Kricker A, Zhang Y, Morton LM, Vajdic CM, Holford TR, Severson RK, Grulich A, Leaderer BP, Davis S, Cozen W, Yeager M, Chanock SJ, Chatterjee N, Rothman N.

PLoS One. 2009;4(4):e5360. doi: 10.1371/journal.pone.0005360. Epub 2009 Apr 24.

6.

PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium.

Nieters A, Conde L, Slager SL, Brooks-Wilson A, Morton L, Skibola DR, Novak AJ, Riby J, Ansell SM, Halperin E, Shanafelt TD, Agana L, Wang AH, De Roos AJ, Severson RK, Cozen W, Spinelli J, Butterbach K, Becker N, de Sanjose S, Benavente Y, Cocco P, Staines A, Maynadié M, Foretova L, Boffetta P, Brennan P, Lan Q, Zhang Y, Zheng T, Purdue M, Armstrong B, Kricker A, Vajdic CM, Grulich A, Smith MT, Bracci PM, Chanock SJ, Hartge P, Cerhan JR, Wang SS, Rothman N, Skibola CF.

Blood. 2012 Nov 29;120(23):4645-8. doi: 10.1182/blood-2012-05-427989. Epub 2012 Oct 9.

7.

Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms: comparison with lymphomas associated with BCL2 rearrangement.

Muramatsu M, Akasaka T, Kadowaki N, Ohno H, Yamabe H, Edamura S, Dor S, Mori T, Okuma M, Fukuhara S.

Br J Haematol. 1996 Jun;93(4):911-20.

PMID:
8703825
8.

Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.

Fernberg P, Chang ET, Duvefelt K, Hjalgrim H, Eloranta S, Sørensen KM, Porwit A, Humphreys K, Melbye M, Ekström Smedby K.

Cancer Causes Control. 2010 May;21(5):759-69. doi: 10.1007/s10552-010-9504-y. Epub 2010 Jan 20.

PMID:
20087644
9.

Association of AMP-activated protein kinase with risk and progression of non-Hodgkin lymphoma.

Hoffman AE, Demanelis K, Fu A, Zheng T, Zhu Y.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):736-44. doi: 10.1158/1055-9965.EPI-12-1014. Epub 2013 Feb 8.

10.

Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.

Kanda-Akano Y, Nomura K, Fujita Y, Horiike S, Nishida K, Nagai M, Miura I, Nakamura S, Seto M, Iida S, Ueda R, Taniwaki M.

Leuk Lymphoma. 2004 Aug;45(8):1559-67.

PMID:
15370207
11.

Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.

Lan Q, Wang SS, Menashe I, Armstrong B, Zhang Y, Hartge P, Purdue MP, Holford TR, Morton LM, Kricker A, Cerhan JR, Grulich A, Cozen W, Zahm SH, Yeager M, Vajdic CM, Schenk M, Leaderer B, Yuenger J, Severson RK, Chatterjee N, Chanock SJ, Zheng T, Rothman N.

Br J Haematol. 2011 May;153(3):341-50. doi: 10.1111/j.1365-2141.2010.08424.x. Epub 2011 Mar 21.

12.

Clinical and biological relevance of single-nucleotide polymorphisms and acquired somatic mutations of the BCL6 first intron in follicular lymphoma.

Jardin F, Ruminy P, Parmentier F, Picquenot JM, Courel MN, Bertrand P, Buchonnet G, Tilly H, Bastard C.

Leukemia. 2005 Oct;19(10):1824-30.

PMID:
16094416
13.

Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.

Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM, Kay NE, Dogan A, Liebow M, Wang AH, Call TG, Habermann TM, Ansell SM, Slager SL.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3161-9. doi: 10.1158/1055-9965.EPI-08-0536.

14.

Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin's lymphoma.

Jiao J, Zheng T, Lan Q, Chen Y, Deng Q, Bi X, Kim C, Holford T, Leaderer B, Boyle P, Ba Y, Xia Z, Chanock SJ, Rothman N, Zhang Y.

Eur J Cancer Prev. 2012 Nov;21(6):580-4.

15.

Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.

Al-Kawaaz M, Mathew S, Liu Y, Gomez ML, Chaviano F, Knowles DM, Orazi A, Tam W.

Am J Clin Pathol. 2015 Feb;143(2):288-99. doi: 10.1309/AJCPUIDW2CPTA1JA.

PMID:
25596256
16.

Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.

Gaidano G, Carbone A, Pastore C, Capello D, Migliazza A, Gloghini A, Roncella S, Ferrarini M, Saglio G, Dalla-Favera R.

Blood. 1997 May 15;89(10):3755-62.

17.

Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.

Malpeli G, Barbi S, Moore PS, Scardoni M, Chilosi M, Scarpa A, Menestrina F.

Haematologica. 2004 Sep;89(9):1091-9.

18.

Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.

Zhang Y, Wang MY, He J, Wang JC, Yang YJ, Jin L, Chen ZY, Ma XJ, Sun MH, Xia KQ, Hong XN, Wei QY, Zhou XY.

PLoS One. 2012;7(5):e37846. doi: 10.1371/journal.pone.0037846. Epub 2012 May 29.

19.

Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.

Wang SS, Menashe I, Cerhan JR, Cozen W, Severson RK, Davis S, Hutchinson A, Rothman N, Chanock SJ, Bernstein L, Hartge P, Morton LM.

Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):42-9. doi: 10.1158/1055-9965.EPI-10-0638. Epub 2010 Dec 10.

20.

Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms.

Muramatsu M, Akasaka T, Kadowaki N, Ohno H, Fukuhara S, Okuma M.

Leukemia. 1997 Apr;11 Suppl 3:318-20.

PMID:
9209377

Supplemental Content

Support Center